全文获取类型
收费全文 | 57370篇 |
免费 | 5755篇 |
国内免费 | 137篇 |
专业分类
耳鼻咽喉 | 572篇 |
儿科学 | 1535篇 |
妇产科学 | 1373篇 |
基础医学 | 8267篇 |
口腔科学 | 1232篇 |
临床医学 | 6997篇 |
内科学 | 10854篇 |
皮肤病学 | 670篇 |
神经病学 | 5429篇 |
特种医学 | 2233篇 |
外国民族医学 | 58篇 |
外科学 | 7914篇 |
综合类 | 1101篇 |
一般理论 | 53篇 |
预防医学 | 6132篇 |
眼科学 | 1335篇 |
药学 | 4020篇 |
中国医学 | 33篇 |
肿瘤学 | 3454篇 |
出版年
2022年 | 414篇 |
2021年 | 1199篇 |
2020年 | 683篇 |
2019年 | 1032篇 |
2018年 | 1171篇 |
2017年 | 890篇 |
2016年 | 955篇 |
2015年 | 1073篇 |
2014年 | 1552篇 |
2013年 | 2142篇 |
2012年 | 3045篇 |
2011年 | 3130篇 |
2010年 | 1772篇 |
2009年 | 1482篇 |
2008年 | 2730篇 |
2007年 | 2676篇 |
2006年 | 2680篇 |
2005年 | 2520篇 |
2004年 | 2447篇 |
2003年 | 2198篇 |
2002年 | 2112篇 |
2001年 | 1543篇 |
2000年 | 1646篇 |
1999年 | 1416篇 |
1998年 | 640篇 |
1997年 | 556篇 |
1996年 | 505篇 |
1995年 | 502篇 |
1994年 | 462篇 |
1993年 | 438篇 |
1992年 | 1106篇 |
1991年 | 1144篇 |
1990年 | 1048篇 |
1989年 | 1031篇 |
1988年 | 1025篇 |
1987年 | 890篇 |
1986年 | 879篇 |
1985年 | 855篇 |
1984年 | 727篇 |
1983年 | 597篇 |
1982年 | 403篇 |
1981年 | 374篇 |
1979年 | 671篇 |
1978年 | 530篇 |
1977年 | 454篇 |
1976年 | 427篇 |
1975年 | 398篇 |
1974年 | 451篇 |
1973年 | 447篇 |
1972年 | 385篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
91.
Molecular biology of urological tumours 总被引:1,自引:0,他引:1
92.
V G Matassa F J Brown P R Bernstein H S Shapiro T P Maduskuie L A Cronk E P Vacek Y K Yee D W Snyder R D Krell 《Journal of medicinal chemistry》1990,33(9):2621-2629
The dissociation constants (KB) at the LTD4 receptor on guinea pig trachea of a series of monocyclic and bicyclic cyclopentylurethane and cyclopentylacetamide N-arylsulfonyl amides have been measured. The KB was found to be remarkably tolerant of changes in the electronic constitution and lipophilicity of the bicyclic ring system (template). Thus, N-[4[[6-[[(cyclopentyloxy)carbonyl]amino]benzimidazol-1- yl]methyl]-3-methoxybenzoyl]benzenesulfonamide (11a) and N-[4-[[5-[[(cyclopentyloxy)carbonyl]amino]benzo[b]thien-3- yl]methyl]-3-methoxybenzoyl]benzene-sulfonamide (25a) had closely similar affinities (pKB, 9.20 and 9.31, respectively; LTE4 as agonist). It has been shown that the hetero-ring of the template need not be aromatic in order to achieve high affinity, since indoline 31 and 2,3-dihydrobenz-1,4-oxazines 37a-c had pKBs greater than 9. Further, it has been shown that an o-aminophenone (see 42 and Figure 3) can function as a template; the template in 42 [see iii] is bicyclic by virtue of the presence of an intramolecular hydrogen bond. In contrast, when the template is a phenyl ring (48), receptor affinity is markedly reduced. These findings support the notion that central bicyclic ring system in this family of peptidoleukotriene antagonists is a molecular feature which helps to preorganize the acylamino and acidic chains and thereby facilitate the molecular recognition event. 相似文献
93.
94.
95.
96.
97.
Dr. Caroline S. Zeind Pharm.D. Dr. Kerry O. Cleveland M.D. Dr. Madhavi Menon M.D. Dr. James R. Brown Pharm.D. Dr. David K. Solomon Pharm.D. 《Pharmacotherapy》1996,16(4):547-561
The optimum therapy for cryptococcal meningitis in patients with the acquired immunodeficiency syndrome (AIDS) remains unresolved. Traditional therapy consists of amphotericin B with or without flucytosine. Obstacles exist in administering these agents to patients with AIDS. Mortality rates during initial therapy are relatively high. Given the lack of proved benefit, we do not recommend adding flucytosine to amphotericin B routinely. The search for more efficacious and less toxic agents continues. The oral triazoles, especially fluconazole, have increased the options for treatment of this disease. New strategies and novel approaches in managing cryptococcal meningitis in patients with AIDS continue to be developed. 相似文献
98.
CM Reid M. Nelson P. Beckinsale P. Ryan LMH Wing LJ Beilin MA Brown GLR Jennings CI Johnston J. Marley JJ McNeil TO Morgan J. Shaw ID Steven MJ West 《Clinical and experimental pharmacology & physiology》1997,24(5):370-373
1. The present study aimed to determine the feasibility of conducting a 5 year cardiovascular outcome trial of the treatment of 6000 elderly hypertensive patients in Australian general practices. 2. General practitioners (GPs) were invited to participate by mail and personal follow-up. Patient records were reviewed to identify subjects for a blood pressure (BP) screening programme. Blood pressure was measured on three occasions and eligible subjects were included if the average BP was 160 mmHg systolic or 90 mmHg diastolic if systolic BP was 140 mmHg. 3. Seven hundred and forty-one GPs were approached and 89 were enrolled in the study (12% of mail invites and 75% of those receiving a personal contact). In 16 practices where screening was completed, 82 000 records were reviewed to identify 4% patients eligible for screening. Twenty-two per cent of eligible subjects attended screening. Of 1938 subjects screened, 180 (9%) had BP 5=160/90 mmHg. Forty-seven percent of subjects (n = 916) were receiving antihypertensive therapy and 184 (20%) were withdrawn from therapy. One hundred and sixteen (63%) of these subjects had BP return to study entry levels within 6 weeks. Fifty-seven newly diagnosed and 81 previously treated subjects were randomized (7% of the screened population). 4. Based on the high participation rate of GPs, the response rate of patients to attend a BP screening programme and the 7% randomization to screening ratio for entry into the study, the ANBP2 pilot study has demonstrated that it is feasible to recruit subjects from Australian general practices to a cardiovascular outcome trial. 相似文献
99.
Use of metoclopramide, domperidone, and cisapride in the management of diabetic gastroparesis 总被引:3,自引:0,他引:3
The pathophysiology, diagnosis, and treatment of diabetic gastroparesis are reviewed, and the mechanisms of action, pharmacokinetics, clinical efficacy, adverse effects, and dosage of metoclopramide, domperidone, and cisapride are described. Diabetic gastroparesis is a state of delayed gastric emptying that reportedly affects 20-30% of diabetic patients. Symptoms include nausea, early satiety, postprandial bloating and fullness, and vomiting. Diabetic gastroparesis has been managed most successfully with drugs that stimulate gastric emptying. Of the three agents studied--metoclopramide, domperidone, and cisapride--only metoclopramide is commercially available in the United States. The clinical efficacy of metoclopramide, domperidone, and cisapride has been well documented in several placebo-controlled trials. Metoclopramide effectively decreases mean gastric emptying time, although tolerance to this stimulation of gastric emptying may develop with long-term therapy. However, symptomatic relief persists with long-term therapy because of metoclopramide's antiemetic properties. Domperidone, which has also been shown to stimulate gastric motility and to possess antiemetic properties, improves symptoms in patients suffering from diabetic gastroparesis. Cisapride appears to have continued beneficial effects on gastric motility with long-term therapy. All three agents have favorable adverse-effect profiles. Although metoclopramide is currently the first-line agent for the management of gastroparesis, domperidone and cisapride both possess properties that may make them useful alternatives in patients who are unresponsive to or cannot tolerate metoclopramide therapy. 相似文献
100.
G. Singh J. F. Hussain A. MacKinnon C. M. Brown D. A. Kendall V. G. Wilson 《Naunyn-Schmiedeberg's archives of pharmacology》1994,351(1):17-26
In the present study we have prepared crude, methanolic extracts of bovine lung and bovine brain and, using radioligand binding assays in conjunction with a number of simple chromatographic techniques, provided evidence for the presence of a non-catecholamine ’clonidine-displacing substance‘ (CDS). The level of CDS in lung extracts (9?units/g wet weight n=11) is approximately 3 times that in the brain extracts. Furthermore, the effect of the crude, methanolic extracts are selective for non-adrenoceptor, imidazoline (labelled by [ 3H]-idazoxan) and a 2-adrenoceptor binding sites (labelled by [ 3H]-clonidine); both extracts are 5–10-fold more potent displacers of ligand binding to a 2-adrenoceptors compared with binding to opiate receptors (labelled by [ 3H]-etorphine) and practically inactive against a 1-adrenoceptor and muscarinic binding sites (labelled by [ 3H]- prazosin and [ 3H]-quinuclidinyl benzilate, respectively). With the exception of the non-adrenoceptor, imidazoline binding assay, which used rat kidney membranes labelled by [ 3H]-idazoxan in the presence of the a 2-adrenoceptor antagonist RS-15385-197, all radioreceptor assays involved bovine cerebral cortex membranes. Although the extracts contain catecholamines (brain only), histamine (lung only) and monovalent cations (both), which have the potential to interfere with the radioligand binding assays, their concentrations were too low to account for the effects observed. Preliminary attempts at purification of the extracts revealed that CDS activities from the two tissues are similar, i.e., practically insoluble in organic solvents at room temperature, not affected by either Sep-Pak C 18 column or anion exchange resins but retained (along with the monovalent cations) by cation exchange resin. However, following chromatographic separation on a Biogel P2 column, the CDS-containing eluates are cation-free and exhibit qualitatively similar elution profiles. Future experiments will involve further purification of ’clonidine-displacing substance‘ to characterize its interaction with a 2-adrenoceptor binding sites in greater detail and establish whether it has biological activity consistent with the properties implied by its effects in radioligand binding assays. 相似文献